Kenneth C. Cundy
Overview
Kenneth C. Cundy received an average of $493K in total compensation, including $201K in salary, at Anebulo Pharmaceuticals between 2022 and 2023. Kenneth Cundy also received an average of $424K at CohBar from 2014 to 2021.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Anebulo PharmaceuticalsChief Scientific Officer
Anebulo PharmaceuticalsChief Scientific Officer
CohBarFormer Chief Scientific Officer
CohBarFormer Chief Scientific Officer
CohBarChief Scientific Officer
CohBarChief Scientific Officer
CohBarChief Scientific Officer
CohBarChief Scientific Officer
CohBarChief Scientific Officer
CohBarChief Scientific Officer
Related executives
We found nine more executives who work or worked at Anebulo Pharmaceuticals and CohBar.
Simon Allen
Anebulo Pharmaceuticals
Chief Executive Officer
Rex Merchant
Anebulo Pharmaceuticals
Chief Financial Officer
Sandra Gardiner
Anebulo Pharmaceuticals
Chief Financial Officer
Daniel Schneeberger
Anebulo Pharmaceuticals
Chief Executive Officer
Joseph Sarret
CohBar
Chief Executive Officer
Jeffrey Biunno
CohBar
Chief Financial Officer
Steven Engle
CohBar
Chief Executive Officer
Jon Stern
CohBar
Chief Operating Officer
News
Anebulo Pharmaceuticals CEO Simon Allen's 2023 pay falls 63% to $778K
October 30, 2023
Anebulo Pharmaceuticals CEO Simon Allen receives $2.1M in 2022
October 17, 2022
CohBar CEO Joseph Sarret receives $3.2M in 2021
April 22, 2022
CohBar CEO Steven Engle receives $2.4M in 2019
April 29, 2020
CohBar CEO Philippe Calais receives $1.6M in 2018
April 24, 2019